Endoscopic nerve decompression and interbody fusion with unilateral pedicle screw fixation in the clinical application.docVIP

 PAGE \* MERGEFORMAT 19 Endoscopic nerve decompression and interbody fusion with unilateral pedicle screw fixation in the clinical application Of: Wang, Zhou Yue, beginning with the Wei, Wang Weidong, Zhang Zhengfeng, Li Changqing, Zhang in the spring, Wen-Jie Zheng, Pan Yong [Abstract] [Objective] To investigate the endoscopic unilateral nerve decompression, interbody fusion and pedicle screw fixation for lumbar degenerative disease of the feasibility and effectiveness. [Method] From June 2004 to 2007 3 months, 20 patients underwent minimally invasive transforaminal lumbar interbody fusion by (TLIF) or posterior interbody fusion (PLIF) surgery. Among them, 11 males and 9 females, aged from 31 to 70 years, mean 46.2 years . preoperative diagnosis included: recurrent lumbar disc herniation in 8 cases, extreme lateral lumbar disc herniation in 4 cases, 3 cases of lumbar spinal stenosis, lumbar instability in 3 cases, 2 cases of discogenic low back pain. All the patients endoscope under the single segmental decompression and interbody fusion and unilateral pedicle screw fixation, in which L4, 5 12 例, L5S1 8 cases. paracentral muscular approach by the working channel placed on the unilateral facet. TLIF facet resection, exposure and removal of disc. PLIF surgery by micro endoscopic discectomy (MED) operations. In METRx or X-tube system to complete the treatment of intervertebral space, autologous implantation of bone and interbody fusion, unilateral pedicle screw fixation. [Results] No cases of conversion to open surgery. operative time 100 ~ 165 min, an average of 115 min. intraoperative blood loss 50 ~ 180 ml, an average of 130 ml. postoperative hospital stay was 7 ~ 15 d, an average of 11 d. low back pain patients before and (or lower extremity pain relief after surgery were .2 patients had new radicular symptoms, 1 case of nerve root compression bone displacement, and the other 1 case of hematoma formation. follow-up 10 39 months, an average of 21.6 month